# Longitudinal Changes in Left Ventricular Geometry After Kidney Transplantation and Their Implications on Cardiovascular Risk

**Authors:** Dong-Hyuk Cho, Jun Gyo Gwon, Jimi Choi, Cheol Woong Jung, Tai Yeon Koo, Se Won Oh, Sang-Kyung Jo, Kyo Won Lee, Kyu Ha Huh, Han Ro, Seung-Yeup Han, Jang-Hee Cho, Sik Lee, Jaeseok Yang, Seong-Mi Park, Myung-Gyu Kim

PMC · DOI: 10.1016/j.xkme.2025.101201 · Kidney Medicine · 2025-12-11

## TL;DR

This study shows that while kidney transplantation improves heart structure, increased heart wall thickness is linked to higher cardiovascular risk, emphasizing the need for metabolic control.

## Contribution

The study identifies that relative wall thickness increase after kidney transplantation independently predicts cardiovascular events, offering new insights into post-transplant cardiac risk management.

## Key findings

- Improved hemodynamic parameters correlate with reduced left ventricular size after kidney transplantation.
- Increased relative wall thickness independently predicts major adverse cardiovascular events.
- Better metabolic control is associated with improved left ventricular wall thickness.

## Abstract

Kidney transplantation (KT) alleviates the hemodynamic burden in chronic kidney disease on dialysis. However, cardiovascular disease remains the leading cause of death after KT. This study evaluated the metabolic and hemodynamic burden and its impact on myocardial remodeling and clinical outcomes after KT.

Multicenter observational prospective cohort study.

600 patients who underwent echocardiography before and 3 years after KT from 8 university hospitals in Korea.

Changes in metabolic parameters (glycosylated hemoglobin [HbA1C] and triglyceride [TG] levels) and hemodynamic parameters (hemoglobin [Hb] and systolic blood pressure [SBP]) from baseline to 3 years after KT.

Primary outcome was major adverse cardiovascular events (MACE). Secondary outcomes included left ventricular geometry changes.

Cox proportional hazards models were used to assess the association between echocardiographic changes and MACE.

TG and HbA1c levels increased 3 years after KT; however, Hb levels and SBP improved (P < 0.05). Left ventricular end-diastolic dimension also improved for 3 years (P < 0.05). Nevertheless, the relative wall thickness (RWT) increased from 0.39 ± 0.07-0.41 ± 0.07. Changes in hemodynamic parameters (Hb level and SBP) were associated with a change in the left ventricular end-diastolic dimension, whereas changes in metabolic parameters (HbA1c and TG levels) were associated with a change in RWT (P < 0.05). During the 5-year follow-up, 30 MACE occurred, and an increase in RWT independently predicted MACE occurrence (hazard ratio, 2.20; 95% confidence interval, 1.21-3.99; P < 0.01).

Only patients with baseline and follow-up echocardiography were included, potentially introducing selection bias.

Hemodynamic improvements are associated with decreased left ventricular size; better metabolic control is associated with greater wall thickness improvement. RWT increases predicted MACE. Optimizing metabolic control to promote balanced left ventricular improvement could enhance cardiovascular outcomes in patients receiving KTs.

Patients receiving a kidney transplant often develop cardiovascular complications despite successful transplantation. To examine how cardiac structure changes posttransplant and their impact on future cardiovascular risk, we analyzed 600 patients in the prospective multicenter cohort, performing echocardiography before and 3 years after transplant. Overall, cardiac structure improved following transplantation, but some developed increased relative wall thickness. Better blood pressure and anemia control showed greater improvement in cardiac chamber size, whereas better glycemic and lipid control achieved superior wall thickness improvement. Importantly, patients with increased relative wall thickness faced twice the risk of major adverse cardiovascular events, including myocardial infarction and stroke. These findings highlight the importance of optimizing metabolic control to promote balanced cardiac remodeling and reduce cardiovascular risk after transplantation.

## Linked entities

- **Chemicals:** triglyceride (PubChem CID 5460048)
- **Diseases:** chronic kidney disease (MONDO:0005300), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Diseases:** death (MESH:D003643), cardiovascular disease (MESH:D002318), chronic kidney disease (MESH:D051436)
- **Chemicals:** TG (MESH:D013866), triglyceride (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12856460/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12856460/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12856460/full.md

---
Source: https://tomesphere.com/paper/PMC12856460